Israel’s InspireMD has announced significant positive results for its trials of its innovative MGuard coronary stent. Wrapped in an expandable mesh, the stent reduces the risk of life-threatening rupture and embolization during and post surgery when compared to traditional bare-metal stents.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000722865